Narla; Rama Krishna

Patent Applications and Registrations

Patent applications and USPTO patent grants for Narla; Rama Krishna.The latest application filed is for "methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)me- thyl)benzyl)amino)isoindoline-1,3-dione".

Company Profile

5.10.13

Narla; Rama Krishna - San Diego CA
Narla; Rama Krishna - St. Paul MN
Narla; Rama Krishna - Shoreview MN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of treating non-Hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)me- thyl)benzyl)amino)isoindoline-1,3-dione Grant 11,390,617 - Anton , et al. July 19, 2	2022-07-19
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith Grant 11,325,889 - Ammirante , et al. May 10, 2	2022-05-10
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith Grant 11,149,007 - Ammirante , et al. October 19, 2	2021-10-19
Methods Of Treating Hematological Malignancies Using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)me- Thyl)benzyl)amino)isoindoline-1,3-dione App 20210113577 - Anton; Maria Soraya Carrancio ; et al.	2021-04-22
Substituted 4-aminoisoindoline-1,3-dione Compounds And Second Active Agents For Combined Use App 20210113576 - Anton; Maria Soraya Carrancio ; et al.	2021-04-22
Methods Of Treating Non-hodgkin Lymphoma Using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)me- Thyl)benzyl)amino)isoindoline-1,3-dione App 20200325129 - Anton; Maria Soraya Carrancio ; et al.	2020-10-15
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione Compounds, Compositions Thereof, And Methods Of Treatment Therewith App 20200199074 - Ammirante; Massimo ; et al.	2020-06-25
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione Compounds, Compositions Thereof, And Methods Of Treatment Therewith App 20200199073 - Ammirante; Massimo ; et al.	2020-06-25
4-((4-(2-Azaperhydroepinylethoxy)phenyl)methyl)-3-2(2,4-dichlorophenyl)-7-- hydroxychromen-2-one, pharmaceutically acceptable salts thereof and methods of use therewith App 20070191343 - Sakata; Steven T. ; et al.	2007-08-16
Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer App 20070123511 - Sakata; Steven T. ; et al.	2007-05-31
Haloanilino quinazolines and therapeutic use thereof Grant 7,038,049 - Uckun , et al. May 2, 2	2006-05-02
Methods of treating diseases and disorders by targeting multiple kinases App 20050107386 - Narla, Rama Krishna ; et al.	2005-05-19
Vanadium compounds for treating proliferative cell disorders Grant 6,878,388 - Uckun , et al. April 12, 2	2005-04-12
Quinazolines and therapeutic use thereof App 20050075353 - Uckun, Fatih M. ; et al.	2005-04-07
6,7-Dimethoxyquinazolines and therapeutic use thereof App 20040039002 - Uckun, Fatih M. ; et al.	2004-02-26
6,7-dimethoxyquinazolines and therapeutic use thereof Grant 6,638,939 - Uckun , et al. October 28, 2	2003-10-28
Quinazolines for treating brain tumor Grant 6,552,027 - Uckun , et al. April 22, 2	2003-04-22
Quinazolines for treating brain tumor App 20020161226 - Uckun, Fatih M. ; et al.	2002-10-31
Quinazolines and therapeutic use thereof App 20020137757 - Uckun, Fatih M. ; et al.	2002-09-26
6,7-Dimethoxyquinazolines and therapeutic use thereof Grant 6,358,962 - Uckun , et al. March 19, 2	2002-03-19
6,7-Dimethoxy-4-anilinoquinazolines Grant 6,316,454 - Uckun , et al. November 13, 2	2001-11-13
Quinazolines and therapeutic use thereof App 20010016588 - Uckun, Fatih M. ; et al.	2001-08-23
Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines Grant 6,258,820 - Uckun , et al. July 10, 2	2001-07-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.